Biotech has been one of the worst-performing industry groups this cycle. Investors have got used to it as these stocks have been dead money for much of the past decade.
Just as we focus on the strongest markets and stocks to find opportunities during equity bull markets, we look to identify the weakest areas during bear markets. We just want to be in the...
Warning signals were piling up throughout 2020, but weak breadth has been an underlying issue for Indian stocks since they made new highs in August 2016.
For those new to the exercise, we take a chart of interest and remove the x/y-axes and any other labels that would help identify it. The chart can be any security in...
We are not seeing any evidence of a bottom for stocks, yet. In these sorts of scenarios we want to see improvements in market breadth and/or bullish momentum divergences start to pile up. We're not seeing any of either.
I'll start by saying: this is no ordinary week. But you knew that.
If you are sitting on the sidelines, waiting for all this craziness to subside, that is not a bad idea at all. There is no reason to put our money at risk if we can't get a...
Every month I host a Conference Call for members of All Star Charts Pro. From the feedback we get from our readers all over the world, this one feature of our...
These are the types of markets that are a statisticians dream come true. They get to run all sorts of scans and tests to see how long it's been since volatility did this or the rate of change in the S&P500 did that. To be honest, it's all a bunch...
